US Broker Ratings

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Growth in Healthcare with 20.39% ROE

Pediatrix Medical Group, Inc. (NYSE: MD) is a prominent player in the healthcare sector, catering specifically to medical care facilities in the United States. With a..

BioCryst Pharmaceuticals, Inc. (BCRX) Rating Update: A Potential 160% Upside Awaits Investors

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has caught the attention of investors with its promising potential upside of 160.73%, according to the latest analyst ratings. Specializing in..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: A Biotech Gem with Over 500% Upside Potential

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a biopharmaceutical innovator, is capturing investor attention with its significant upside potential. With a market capitalization of $389.83 million, this San..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a Potential 92% Upside in the Biotech Sector

MiMedx Group, Inc. (NASDAQ: MDXG), a prominent player in the biotechnology sector, presents an intriguing opportunity for investors seeking high potential returns. With a market capitalization..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Unveiling a 60% Upside Potential Amid Robust Revenue Growth

PTC Therapeutics, Inc. (NASDAQ: PTCT), a prominent player in the biotechnology sector, is catching investor attention with its substantial market cap of $5.1 billion and an..

Acadia Healthcare Company, Inc. (ACHC)

⚠️ No article content returned.

..

MannKind Corporation (MNKD) Stock Analysis: A Potential 150% Upside in the Healthcare Sector

MannKind Corporation (MNKD), a prominent player in the biotechnology industry, offers a compelling investment opportunity with a potential upside of 150.26%. As a biopharmaceutical company dedicated..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Assessing the 10.96% Potential Upside Amidst Market Challenges

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands at a pivotal moment, presenting a potential upside of 10.96% according to analyst projections. As a key player in the..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Investors Eye 162% Potential Upside in Biotechnology Breakthroughs

Investors looking for opportunities in the biotechnology sector may want to keep a close watch on Vera Therapeutics, Inc. (NASDAQ: VERA). With a market capitalization of..

Supernus Pharmaceuticals (SUPN) Investor Outlook: Evaluating a 48.39% Potential Upside Amid Robust CNS Portfolio

Supernus Pharmaceuticals, Inc. (SUPN), a U.S.-based biopharmaceutical company, has been making waves in the healthcare sector with its innovative treatments for central nervous system (CNS) diseases...

Zai Lab Limited (ZLAB) Stock Analysis: Biotech Innovation with a 37% Upside Potential

Zai Lab Limited (NASDAQ: ZLAB) is a prominent player in the biotechnology sector, focusing on cutting-edge solutions in oncology, immunology, neuroscience, and infectious diseases. Based in..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a 50% Potential Upside with Robust Revenue Growth

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical company focused on rare kidney and metabolic diseases, is capturing investor attention with its impressive revenue growth and substantial..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring a 34.49% Potential Upside Amidst Financial Challenges

Investors eyeing the healthcare sector might find DENTSPLY SIRONA Inc. (NASDAQ: XRAY) an intriguing prospect, especially with a notable potential upside of 34.49% based on analyst..

Veracyte, Inc. (VCYT) Stock Analysis: A 23.92% Potential Upside with a Strong Buy Consensus

Veracyte, Inc. (NASDAQ: VCYT) stands out in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $3.87 billion, Veracyte has..

Kymera Therapeutics, Inc. (KYMR) Growth Potential: A 21% Upside with Strong Buy Ratings

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a promising player in the biotechnology sector, is capturing investor attention with its innovative approach to drug development and a compelling..

IDEAYA Biosciences, Inc. (IDYA)

⚠️ No article content returned.

..

Indivior Pharmaceuticals (INDV) Stock Analysis: Unveiling a 41.78% Potential Upside

Investors eyeing opportunities in the healthcare sector might find Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) an intriguing prospect. This U.S.-based drug manufacturer specializes in treatments for opioid..

Astrana Health Inc. (ASTH) Stock Analysis: A Promising 38.78% Upside in the Healthcare Sector

As investors navigate the intricate landscape of the healthcare sector, Astrana Health Inc. (NASDAQ: ASTH) emerges as a compelling proposition. With a market capitalization of $1.85..

AdaptHealth Corp. (AHCO) Stock Analysis: Investor Outlook with Nearly 50% Potential Upside

AdaptHealth Corp. (NASDAQ: AHCO) presents an intriguing opportunity for investors with its significant potential upside, despite facing some challenging financial metrics. As a key player in..

Alvotech (ALVO) Stock Analysis: Potential Upside of 55.84% Draws Investor Attention

Alvotech (NASDAQ: ALVO), a Luxembourg-based biopharmaceutical company specializing in biosimilar medicines, is capturing investor interest with a compelling potential upside of 55.84%, according to recent analyst..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds